PMC:7784830 / 26835-27103 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"429","span":{"begin":51,"end":54},"obj":"Gene"},{"id":"431","span":{"begin":253,"end":261},"obj":"Species"},{"id":"434","span":{"begin":25,"end":31},"obj":"Disease"},{"id":"435","span":{"begin":167,"end":170},"obj":"Disease"},{"id":"436","span":{"begin":246,"end":252},"obj":"Disease"}],"attributes":[{"id":"A429","pred":"tao:has_database_id","subj":"429","obj":"Gene:7490"},{"id":"A431","pred":"tao:has_database_id","subj":"431","obj":"Tax:9606"},{"id":"A434","pred":"tao:has_database_id","subj":"434","obj":"MESH:D009369"},{"id":"A435","pred":"tao:has_database_id","subj":"435","obj":"MESH:C537262"},{"id":"A436","pred":"tao:has_database_id","subj":"436","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Nitto Denko Corporation Cancer vaccine comprising WT1 peptide or Db126 along with a promoter namely lipopolysaccharide or quercetin or ioxoprofen Mannitol, PEG, and HPC PEG, mannitol SCM Composition successfully induces cellular immunity in cancer patients [127]"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":25,"end":31},"obj":"Phenotype"},{"id":"T10","span":{"begin":246,"end":252},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Nitto Denko Corporation Cancer vaccine comprising WT1 peptide or Db126 along with a promoter namely lipopolysaccharide or quercetin or ioxoprofen Mannitol, PEG, and HPC PEG, mannitol SCM Composition successfully induces cellular immunity in cancer patients [127]"}

{"project":"LitCovid-sentences","denotations":[{"id":"T210","span":{"begin":0,"end":268},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Nitto Denko Corporation Cancer vaccine comprising WT1 peptide or Db126 along with a promoter namely lipopolysaccharide or quercetin or ioxoprofen Mannitol, PEG, and HPC PEG, mannitol SCM Composition successfully induces cellular immunity in cancer patients [127]"}